✦ LIBER ✦

194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)

✍ Scribed by A. Urruticoechea; P. Canney; R. Separovic; T. Bachelot; J. Efran; J.L. Canon; P. Martinez del Prado; C. Barone; K. Mayne; M. Munoz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

446 PUBLICATION A phase II trial of tras

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II Interventional Study (N0337) of

✍ Winston W. Tan; Jacob B. Allred; Muhammad Salim; Patrick Flynn; Paul A.S. Fishki 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 354 KB

2134 POSTER Clinical benefit of trastuzu

✍ P. Chollet; X. Durando; L. Mauriac; C. Delcambre; P. Maillart; C. Veyret; M.A. M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A phase I/II trial of non-pegylated lipo

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A multicenter phase II study of epirubic

✍ M. Zilli; De Tursi; C. Carella; E. Ricevuto; P. Marchetti; A. Gennari; C. Orland 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB